Skip to Main Content

Paper Details

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Ann Oncol
573
2020
KN158, NSCLC, TMB, advanced non-squamous non-small-cell lung cancer, cancers, cervical cancers, cholangiocarcinoma, colon cancers, endometrial and small-cell lung cancers, genes, metastatic cancers, multigene, multigene panels, nucleotides, ovarian cancers, patient, patients, prostate cancers, salivary cancers, thyroid cancers, tumour, tumours, vulvar cancers, well- and moderately-differentiated neuroendocrine tumours
Author NameAffiliation
Joaquin MateoClinical Research Program, Vall Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital
Martijn P LolkemaErasmus MC Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Nikhil WagleDana-Farber Cancer Institute and Harvard Medical School
Nikhil WagleDana-Farber Cancer Institute and Harvard Medical School
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Rodrigo DienstmannVall d'Hebron Institute of Oncology
  • 1 - 8

Datasets

Release 1.2